Related Experiment Video
Updated: Feb 18, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Factors associated with peripheral blood stem cell yield in healthy pediatric donors
Gülsün Karasu1, Vedat Uygun1, Akif Yesilipek1
1Medicalpark Antalya Hospital, Pediatric Stem Cell Transplantation Unit, Antalya, Turkey.
Insights
Predicting stem cell yield in pediatric donors is crucial. Donor weight ratio and circulating CD34+ cell counts on apheresis day help predict peripheral blood stem cell (PBSC) yield in children.
Area of Science:
- Pediatric Hematology
- Stem Cell Transplantation
- Apheresis Procedures
Background:
- Limited data exists on predictive factors for CD34+ stem cell yield in healthy pediatric donors.
- Peripheral blood stem cell (PBSC) donation is utilized in children, necessitating understanding of donor-specific variables.
Purpose of the Study:
- To identify predictive factors for achieving a target CD34+ stem cell dose (>3×10^6/kg recipient body weight) in pediatric PBSC donors.
- To analyze the relationship between donor age, weight, and CD34+ cell yield.
Main Methods:
- Retrospective analysis of 140 apheresis procedures in 100 healthy pediatric donors.
- Donors categorized into four age groups (0-4, 5-9, 10-14, 15-18 years).
- Multivariate analysis to determine significant predictors of CD34+ cell collection.
Main Results:
- The median CD34+ cell yield in the first apheresis was 3.9×10^6/kg recipient body weight.
- No statistically significant difference in CD34+ cell yield was observed among the different age groups.
- Donor-to-recipient weight ratio and peripheral CD34+ cell count were significant predictors for achieving >3×10^6/kg RBW of CD34+ cells.
Conclusions:
- Circulating CD34+ cell concentration on apheresis day is a key predictor of stem cell yield in pediatric donors.
- The donor-to-recipient weight ratio also plays a significant role in predicting successful CD34+ stem cell collection.
- These factors can aid in optimizing apheresis procedures for pediatric donors.
Background And Objectives:
Although several studies have reported on the use of children as donors for peripheral blood stem cells (PBSC), data on the predictive factors of CD34+ stem cell yield in healthy pediatric donors are very limited.
Design And Method:
We retrospectively analyzed factors predicting the yield for a target CD34 cell dose of >3×106/kg recipient body weight in 140 apheresis in 100 healthy pediatric donors. The donors were evaluated in four groups assigned according to their ages of being 0-4 years, 5-9 years, 10-14 years and 15-18 years. 38 donors underwent second apheresis, two of which required third apheresis.
Results:
Median age and body weight were 9.8 years (range: 2-18 years) and 35.8kg (range 11-84kg), respectively. The median number of CD34+ cells in first apheresis was 3.9×106/kg of recipient body weight (RBW) (range: 0.03-33×106/kg RBW). Sixty-two out of 100 donors (62%) needed only one apheresis. The CD34+ cell count in stem cell product and the amount of CD34+ cell yield considering donors' body weight obtained from the first apheresis was not statistically different among defined age groups. On multivariate analysis, variables that had a significant impact on CD34+ cell collection being more than 3×106kg RBW were donor to recipient weight ratio and periperal CD34+ cell count.
Conclusion:
Our data suggest that CD34+ stem cell yield can be predicted from circulating CD34+ cell concentration on apheresis day and donor to recipient weight ratio in healthy pediatric donors.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Regulation of Hematopoietic Stem Cells
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Multipotency of Hematopoietic Stem Cells

